Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma

The objective of this study is to present the complete biomarker response dataset from a pivotal trial evaluating the efficacy and safety of high-specific-activity I-131 meta-iodobenzylguanidine in patients with advanced pheochromocytoma or paraganglioma. Biomarker status was assessed and post-treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jimenez, Camilo, Chin, Bennett B, Noto, Richard B, Dillon, Joseph S, Solnes, Lilja, Stambler, Nancy, DiPippo, Vincent A, Pryma, Daniel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874967/
https://www.ncbi.nlm.nih.gov/pubmed/36472300
http://dx.doi.org/10.1530/ERC-22-0236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874967/
https://www.ncbi.nlm.nih.gov/pubmed/36472300
http://dx.doi.org/10.1530/ERC-22-0236

Ejemplares similares